Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2021-04-20 AGM Information
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Uchwały podjęte na Zwyczajnym Walnym Zgromadzeniu - Content (PL)
AGM Information Classification · 95% confidence The document text is very short (284 characters) and explicitly states that the management ('Zarząd') of Mercator Medical S.A. is 'transmitting in the attachment to this report the content of the resolutions adopted at the Ordinary General Meeting' ('przekazuje w załączeniu do niniejszego raportu treść uchwał podjętych na Zwyczajnym Walnym Zgromadzeniu Spółki'). This structure—a brief announcement transmitting the actual content elsewhere (implied attachment or linked document)—fits the definition of a Report Publication Announcement (RPA) or potentially an AGM-R if the content is the resolutions themselves. Since the text is an announcement *about* the resolutions from the AGM, and it is extremely brief, it aligns best with RPA (Rule 2: Menu vs Meal). However, because the content is specifically the resolutions from the AGM, AGM-R is also highly relevant. Given the context of transmitting resolutions from the AGM, AGM-R is the most specific fit for the content being announced, even if the announcement mechanism is brief like an RPA. I will classify it as AGM-R as the core subject is the AGM resolutions.
2021-04-20 Polish
Zawarcie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 94% confidence The document is a short announcement (730 characters) from the Management Board ('Zarząd') of Mercator Medical S.A. It details the signing of a supply agreement for nitrile gloves between a subsidiary and a New Zealand-based recipient. The agreement has a significant value (approx. PLN 307.3 million) and covers deliveries over a specific period (June 2021 to February 2022). This type of announcement concerns a major commercial contract or transaction that impacts the company's operations and financial outlook, but it is not a standard regulatory filing like a 10-K, an earnings release, or a dividend notice. Given the options, this best fits under a general 'Regulatory Filing' (RNS) as a significant corporate event announcement that doesn't fit the more specific categories like M&A (TAR) or Capital Change (CAP). It is not a Call Transcript (CT), Director's Dealing (DIRS), or a formal Audit Report (AR). Since it is a notification of a significant contract, RNS is the most appropriate fallback.
2021-03-30 Polish
Dokumenty Rady Nadzorczej
Governance Information Classification · 95% confidence The document is titled "SPRAWOZDANIE RADY NADZORCZEJ MERCATOR MEDICAL S.A. ZA ROK 2020" (Supervisory Board Report of Mercator Medical S.A. for the Year 2020). It details the composition and activities of the Supervisory Board, its assessment of the 2020 Financial Statements and Management Report, and provides a summary of the company's and Group's performance for the year 2020, including financial results, investment plans, and debt structure. This content strongly aligns with the requirements of a comprehensive annual report or a significant section thereof, specifically focusing on the oversight and review functions typically found in annual filings. Given the comprehensive nature covering the full fiscal year (2020) and the detailed review of financial statements and management reports, it is most closely related to the Annual Report (10-K) structure, although it is specifically the Supervisory Board's report component. Since the provided definitions do not have a specific code for a 'Supervisory Board Report', we must choose the closest fit. It is not a short announcement (RPA/RNS), nor is it just an Audit Report (AR) or an Earnings Release (ER). It contains management discussion and analysis elements related to the full year's performance, making it highly related to the Annual Report (10-K). However, in many jurisdictions, the Supervisory Board's report is a distinct, mandatory component of the overall Annual Report package. Given the options, and its focus on the full year's performance review and approval of financial statements, it is best classified as part of the overall Annual Reporting cycle. If this were a standalone filing, it might fit under Governance Information (CGR) or Audit Report (AR) due to the review of financials, but its scope is broader, covering the entire year's oversight. Since it is a detailed report covering the entire year's activities and assessment of the full annual financials, it is most analogous to the comprehensive nature of the 10-K, or potentially a Governance Report (CGR) if viewed strictly as a board activity report. Given the detailed financial review and assessment of the full-year statements, I will classify it as related to the Annual Report structure, but since it is explicitly the Supervisory Board's report, which often accompanies the 10-K, and contains governance elements, CGR is also a strong candidate. Reviewing the definitions: 10-K is the 'Official yearly report covering company activity and full financial performance.' This document is the Supervisory Board's assessment of that performance. CGR is 'Report detailing the company's internal rules, board structure, and governance practices.' This document heavily details board structure and governance practices (Section I & II) and the assessment of management's performance. Given the strong emphasis on the Board's activities, composition, and governance oversight (including audit committee functions), CGR is a very precise fit for the content provided, even though it reviews the 2020 financials.
2021-03-28 Polish
Uchwały Rady Nadzorczej - Content (PL)
Report Publication Announcement Classification · 99% confidence The document is a short announcement (611 characters) from the Management Board of Mercator Medical S.A. It states that the board is making public two items: (1) the content of the Supervisory Board's Report, which includes a positive opinion regarding the proposal to use the entire net profit for 2020 for a share repurchase program, and (2) the Supervisory Board's resolution regarding opinions on matters to be resolved by the Ordinary General Meeting (OGM) scheduled for April 20, 2021. Since this is a brief announcement detailing the content of reports/opinions and the scheduling of a General Meeting, and it is not the full report itself, it fits best as a general Regulatory Filing (RNS) or potentially related to AGM/Share repurchase. Given the content focuses on announcing the Supervisory Board's opinion on profit allocation for share repurchase and matters for the upcoming OGM, RNS is the most appropriate general regulatory announcement category, as it is not a full AGM presentation (AGM-R), a full Annual Report (10-K), or a specific dividend notice (DIV). It is an announcement of internal governance/shareholder meeting preparatory documents.
2021-03-28 Polish
Projekty uchwał ZWZ
AGM Information Classification · 100% confidence The document text consists entirely of numbered resolutions ('Uchwała Nr X') passed by the 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) of Mercator Medical S.A. on April 20, 2021. Key topics covered include the election of the Chairman, approval of the agenda (which lists review of 2020 financial statements and management reports), approval of the 2020 Financial Statements, approval of the 2020 Management Report, resolution on profit distribution, granting of discharge (absolutorium) to Board and Supervisory Board members for 2020, and authorization for share buybacks. These documents are the formal record of decisions made during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2021-03-25 Polish
Projekty uchwał Zwyczajnego Walnego Zgromadzenia - Content (PL)
AGM Information Classification · 95% confidence The document text is very short (323 characters) and explicitly states that the management ('Zarząd') is publishing the content of draft resolutions ('treść projektów uchwał') intended for discussion at the Annual General Meeting ('Zwyczajnego Walnego Zgromadzenia Spółki') scheduled for April 20, 2021. It concludes by stating that the content of these draft resolutions constitutes an attachment to the current report ('Treść projektów uchwał stanowi załącznik do niniejszego raportu bieżącego'). This structure—announcing materials for an AGM and stating the materials are attached—strongly suggests this is an announcement about the AGM agenda/proposals rather than the full AGM presentation itself. However, given the specific options, the content directly relates to the items to be voted on at the AGM. The closest fit for materials related to the AGM, especially draft resolutions, is AGM Information (AGM-R). If this were purely an announcement of the meeting date/agenda without resolutions, RPA might apply, but since the resolutions are the core content being announced, AGM-R is the most appropriate classification for the subject matter.
2021-03-25 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.